Altered activity-rest patterns in mice with a human autosomal-dominant nocturnal frontal lobe epilepsy mutation in the Β2 nicotinic receptor

Molecular Psychiatry

Volumn 16, Issue 10, 2011, Pages 1048-1061

  Xu, J ^a,b   Cohen, B N ^c   Zhu, Y ^a,b   Dziewczapolski, G ^b   Panda, S ^b   Lester, H A ^c   Heinemann, S F ^b   Contractor, A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

2* nicotinic receptor; ADNFLE; knock in mouse

Indexed keywords

LEUCINE; NICOTINIC RECEPTOR BETA2; VALINE;

ABNORMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; FRONTAL LOBE EPILEPSY; GENE TARGETING; GENOME ANALYSIS; HUMAN; LIGHT DARK CYCLE; MAZE TEST; MISSENSE MUTATION; MOUSE; NOCTURNAL SEIZURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SLEEP PATTERN;

ANIMALS; CHIMERA; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; EPILEPSY, FRONTAL LOBE; EXPLORATORY BEHAVIOR; GENE KNOCK-IN TECHNIQUES; HUMANS; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; MOTOR ACTIVITY; RECEPTORS, NICOTINIC; SLEEP; WAKEFULNESS;

EID: 80053132114     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2010.78     Document Type: Article

References (75)

1. Karlin A, Akabas MH. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins. Neuron 1995; 15: 1231-1244. (Pubitemid 26005363)
2. McGehee DS, Role LW. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 1995; 57: 521-546.
3. Sargent PB. The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 1993; 16: 403-443. (Pubitemid 23074014)
4. Whiting P, Lindstrom J. Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc Natl Acad Sci USA 1987; 84: 595-599. (Pubitemid 17006242)
5. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J et al. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 1989; 284: 314-335. (Pubitemid 19185398)
6. Zoli M, Lena C, Picciotto MR, Changeux JP. Identification of four classes of brain nicotinic receptors using beta2 mutant mice. J Neurosci 1998; 18: 4461-4472. (Pubitemid 28280157)
7. Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 2007; 47: 699-729.
8. Picciotto MR, Zoli M, Lena C, Bessis A, Lallemand Y, Le Novere N et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 1995; 374: 65-67.
9. Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM et al. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 1998; 391: 173-177. (Pubitemid 28092475)
10. Avale ME, Faure P, Pons S, Robledo P, Deltheil T, David DJ et al. Interplay of beta2* nicotinic receptors and dopamine pathways in the control of spontaneous locomotion. Proc Natl Acad Sci USA 2008; 105: 15991-15996.
11. Granon S, Faure P, Changeux JP. Executive and social behaviors under nicotinic receptor regulation. Proc Natl Acad Sci USA 2003; 100: 9596-9601. (Pubitemid 37033973)
12. Maubourguet N, Lesne A, Changeux JP, Maskos U, Faure P. Behavioral sequence analysis reveals a novel role for beta2* nicotinic receptors in exploration. PLoS Comput Biol 2008; 4: e1000229.
13. Cohen G, Han ZY, Grailhe R, Gallego J, Gaultier C, Changeux JP et al. Beta 2 nicotinic acetylcholine receptor subunit modulates protective responses to stress: a receptor basis for sleep-disordered breathing after nicotine exposure. Proc Natl Acad Sci USA 2002; 99: 13272-13277.
14. Lena C, Popa D, Grailhe R, Escourrou P, Changeux JP, Adrien J. Beta2-containing nicotinic receptors contribute to the organization of sleep and regulate putative micro-arousals in mice. J Neurosci 2004; 24: 5711-5718. (Pubitemid 38857225)
15. De Fusco M, Becchetti A, Patrignani A, Annesi G, Gambardella A, Quattrone A et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000; 26: 275-276.
16. Bertrand D, Picard F, Le Hellard S, Weiland S, Favre I, Phillips H et al. How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia 2002; 43(Suppl 5): 112-122. (Pubitemid 34864217)
17. Fonck C, Cohen BN, Nashmi R, Whiteaker P, Wagenaar DA, Rodrigues-Pinguet N et al. Novel seizure phenotype and sleep disruptions in knock-in mice with hypersensitive alpha 4* nicotinic receptors. J Neurosci 2005; 25: 11396-11411. (Pubitemid 43083712)
18. Son CD, Moss FJ, Cohen BN, Lester HA. Nicotine normalizes intracellular subunit stoichiometry of nicotinic receptors carrying mutations linked to autosomal dominant nocturnal frontal lobe epilepsy. Mol Pharmacol 2009; 75: 1137-1148.
19. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. Derivation of completely cell culture-derived mice from earlypassage embryonic stem cells. Proc Natl Acad Sci USA 1993; 90: 8424-8428. (Pubitemid 23277681)
20. O'Gorman S, Dagenais NA, Qian M, Marchuk Y. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc Natl Acad Sci USA 1997; 94: 14602-14607. (Pubitemid 28041420)
21. Dobelis P, Hutton S, Lu Y, Collins AC. GABAergic systems modulate nicotinic receptor-mediated seizures in mice. J Pharmacol Exp Ther 2003; 306: 1159-1166. (Pubitemid 37025327)
22. Fonck C, Nashmi R, Deshpande P, Damaj MI, Marks MJ, Riedel A et al. Increased sensitivity to agonist-induced seizures, straub tail, and hippocampal theta rhythm in knock-in mice carrying hypersensitive alpha 4 nicotinic receptors. J Neurosci 2003; 23: 2582-2590. (Pubitemid 36418592)
23. Xu J, Zhu Y, Contractor A, Heinemann SF. mGluR5 has a critical role in inhibitory learning. J Neurosci 2009; 29: 3676-3684.
24. Annegers JF, Coan SP. SUDEP: overview of definitions and review of incidence data. Seizure 1999; 8: 347-352. (Pubitemid 29469324)
25. Shao XM, Tan W, Xiu J, Puskar N, Fonck C, Lester HA et al. Alpha4* nicotinic receptors in preBotzinger complex mediate cholinergic/nicotinic modulation of respiratory rhythm. J Neurosci 2008; 28: 519-528.
26. Marini C, Guerrini R. The role of the nicotinic acetylcholine receptors in sleep-related epilepsy. Biochem Pharmacol 2007; 74: 1308-1314. (Pubitemid 47417923)
27. Vignatelli L, Bisulli F, Naldi I, Ferioli S, Pittau F, Provini F et al. Excessive daytime sleepiness and subjective sleep quality in patients with nocturnal frontal lobe epilepsy: a case-control study. Epilepsia 2006; 47(Suppl 5): 73-77. (Pubitemid 44924197)
28. Zucconi M, Oldani A, Smirne S, Ferini-Strambi L. The macrostructure and microstructure of sleep in patients with autosomal dominant nocturnal frontal lobe epilepsy. J Clin Neurophysiol 2000; 17: 77-86. (Pubitemid 30104551)
29. Werme M, Messer C, Olson L, Gilden L, Thoren P, Nestler EJ et al. Delta FosB regulates wheel running. J Neurosci 2002; 22: 8133-8138. (Pubitemid 35379119)
30. Iversen IH. Techniques for establishing schedules with wheel running as reinforcement in rats. J Exp Anal Behav 1993; 60: 219-238.
31. Fowler CD, Arends MA, Kenny PJ. Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice. Behav Pharmacol 2008; 19: 461-484.
32. Booker TK, Butt CM, Wehner JM, Heinemann SF, Collins AC. Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice. Pharmacol Biochem Behav 2007; 87: 146-157. (Pubitemid 46855829)
33. Salas R, Pieri F, Fung B, Dani JA, De Biasi M. Altered anxietyrelated responses in mutant mice lacking the beta4 subunit of the nicotinic receptor. J Neurosci 2003; 23: 6255-6263. (Pubitemid 36875627)
34. Picciotto MR, Brunzell DH, Caldarone BJ. Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 2002; 13: 1097-1106. (Pubitemid 34722033)
35. Damaj MI, Glassco W, Dukat M, Martin BR. Pharmacological characterization of nicotine-induced seizures in mice. J Pharmacol Exp Ther 1999; 291: 1284-1291.
36. Miner LL, Collins AC. Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors. Pharmacol Biochem Behav 1989; 33: 469-475. (Pubitemid 19245538)
37. Teper Y, Whyte D, Cahir E, Lester HA, Grady SR, Marks MJ et al. Nicotine-induced dystonic arousal complex in a mouse line harboring a human autosomal-dominant nocturnal frontal lobe epilepsy mutation. J Neurosci 2007; 27: 10128-10142. (Pubitemid 47450462)
38. Klaassen A, Glykys J, Maguire J, Labarca C, Mody I, Boulter J. Seizures and enhanced cortical GABAergic inhibition in two mouse models of human autosomal dominant nocturnal frontal lobe epilepsy. Proc Natl Acad Sci USA 2006; 103: 19152-19157. (Pubitemid 350002842)
39. Keil W, Kluge A. Ü ber die anwendung des mäuseschwanzphä nomens zur auswertung von morphin-und skopolaminpräparaten. Naunyn Schmiedebers Arch Pharmakol 1934; 174: 493-501.
40. Steinlein OK, Mulley JC, Propping P, Wallace RH, Phillips HA, Sutherland GR et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 1995; 11: 201-203.
41. Hirose S, Iwata H, Akiyoshi H, Kobayashi K, Ito M,Wada K et al. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology 1999; 53: 1749-1753. (Pubitemid 29530350)
42. Diaz-Otero F, Quesada M, Morales-Corraliza J, Martinez-Parra C, Gomez-Garre P, Serratosa JM. Autosomal dominant nocturnal frontal lobe epilepsy with a mutation in the CHRNB2 gene. Epilepsia 2008; 49: 516-520. (Pubitemid 351294529)
43. Phillips HA, Favre I, Kirkpatrick M, Zuberi SM, Goudie D, Heron SE et al. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 2001; 68: 225-231. (Pubitemid 32048378)
44. Manfredi I, Zani AD, Rampoldi L, Pegorini S, Bernascone I, Moretti M et al. Expression of mutant beta2 nicotinic receptors during development is crucial for epileptogenesis. Hum Mol Genet 2009; 18: 1075-1088.
45. Leniger T, Kananura C, Hufnagel A, Bertrand S, Bertrand D, Steinlein OK. A new Chrna4 mutation with low penetrance in nocturnal frontal lobe epilepsy. Epilepsia 2003; 44: 981-985. (Pubitemid 36842192)
46. McLellan A, Phillips HA, Rittey C, Kirkpatrick M, Mulley JC, Goudie D et al. Phenotypic comparison of two Scottish families with mutations in different genes causing autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia 2003; 44: 613-617.
47. Cho YW, Motamedi GK, Laufenberg I, Sohn SI, Lim JG, Lee H et al. A Korean kindred with autosomal dominant nocturnal frontal lobe epilepsy and mental retardation. Arch Neurol 2003; 60: 1625-1632. (Pubitemid 37443131)
48. Magnusson A, Stordal E, Brodtkorb E, Steinlein O. Schizophrenia, psychotic illness and other psychiatric symptoms in families with autosomal dominant nocturnal frontal lobe epilepsy caused by different mutations. Psychiatr Genet 2003; 13: 91-95. (Pubitemid 36724537)
49. Derry CP, Heron SE, Phillips F, Howell S, MacMahon J, Phillips HA et al. Severe autosomal dominant nocturnal frontal lobe epilepsy associated with psychiatric disorders and intellectual disability. Epilepsia 2008; 49: 2125-2129.
50. Combi R, Dalpra L, Tenchini ML, Ferini-Strambi L. Autosomal dominant nocturnal frontal lobe epilepsy-a critical overview. J Neurol 2004; 251: 923-934. (Pubitemid 39119310)
51. Oldani A, Zucconi M, Asselta R, Modugno M, Bonati MT, Dalpra L et al. Autosomal dominant nocturnal frontal lobe epilepsy. A video-polysomnographic and genetic appraisal of 40 patients and delineation of the epileptic syndrome. Brain 1998; 121(Part 2): 205-223. (Pubitemid 28075798)
52. Ryvlin P, Rheims S, Risse G. Nocturnal frontal lobe epilepsy. Epilepsia 2006; 47(Suppl 2): 83-86. (Pubitemid 44684630)
53. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002; 109: 307-320. (Pubitemid 34606874)
54. O'Hara BF, Edgar DM, Cao VH, Wiler SW, Heller HC, Kilduff TS et al. Nicotine and nicotinic receptors in the circadian system. Psychoneuroendocrinology 1998; 23: 161-173. (Pubitemid 28248469)
55. Miller JD, Murakami DM, Fuller CA. The response of suprachiasmatic neurons of the rat hypothalamus to photic and nicotinic stimuli. J Neurosci 1987; 7: 978-986. (Pubitemid 17055342)
56. Marrosu F, Portas C, Mascia MS, Casu MA, Fa M, Giagheddu M et al. Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Res 1995; 671: 329-332.
57. Saint-Mleux B, Eggermann E, Bisetti A, Bayer L, Machard D, Jones BE et al. Nicotinic enhancement of the noradrenergic inhibition of sleep-promoting neurons in the ventrolateral preoptic area. J Neurosci 2004; 24: 63-67. (Pubitemid 38181670)
58. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux JP et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 2005; 436: 103-107. (Pubitemid 40966193)
59. Kelley AE, Berridge KC. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 2002; 22: 3306-3311. (Pubitemid 37465733)
60. Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC et al. Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 2004; 65: 1526-1535. (Pubitemid 38668310)
61. Mansvelder HD, Keath JR, McGehee DS. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 2002; 33: 905-919. (Pubitemid 34246356)
62. Zhou FM, Liang Y, Dani JA. Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 2001; 4: 1224-1229. (Pubitemid 33135628)
63. Cui C, Booker TK, Allen RS, Grady SR, Whiteaker P, Marks MJ et al. The beta3 nicotinic receptor subunit: a component of alphaconotoxin Mll-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. J Neurosci 2003; 23: 11045-11053. (Pubitemid 37548938)
64. Ross SA, Wong JY, Clifford JJ, Kinsella A, Massalas JS, Horne MK et al. Phenotypic characterization of an alpha 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. J Neurosci 2000; 20: 6431-6441.
65. Labarca C, Schwarz J, Deshpande P, Schwarz S, Nowak MW, Fonck C et al. Point mutant mice with hypersensitive alpha 4 nicotinic receptors show dopaminergic deficits and increased anxiety. Proc Natl Acad Sci USA 2001; 98: 2786-2791. (Pubitemid 32209561)
66. Brioni JD, O'Neill AB, Kim DJ, Decker MW. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur J Pharmacol 1993; 238: 1-8. (Pubitemid 23197854)
67. Caldarone BJ, King SL, Picciotto MR. Sex differences in anxietylike behavior and locomotor activity following chronic nicotine exposure in mice. Neurosci Lett 2008; 439: 187-191.
68. Belzung C, Le Pape G. Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiol Behav 1994; 56: 623-628. (Pubitemid 24269590)
69. West RJ, Jarvis MJ. Effects of nicotine on finger tapping rate in nonsmokers. Pharmacol Biochem Behav 1986; 25: 727-731. (Pubitemid 17179884)
70. Marks MJ, Burch JB, Collins AC. Genetics of nicotine response in four inbred strains of mice. J Pharmacol Exp Ther 1983; 226: 291-302. (Pubitemid 13026216)
71. Marubio LM, Paylor R. Impaired passive avoidance learning in mice lacking central neuronal nicotinic acetylcholine receptors. Neuroscience 2004; 129: 575-582. (Pubitemid 39487111)
72. Drenan RM, Grady SR, Whiteaker P, McClure-Begley T, McKinney S, Miwa JM et al. In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors. Neuron 2008; 60: 123-136.
73. Schildein S, Huston JP, Schwarting RK. Open field habituation learning is improved by nicotine and attenuated by mecamylamine administered posttrial into the nucleus accumbens. Neurobiol Learn Mem 2002; 77: 277-290. (Pubitemid 34971642)
74. Conners CK, Levin ED, Sparrow E, Hinton SC, Erhardt D, Meck WH et al. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol Bull 1996; 32: 67-73. (Pubitemid 26176204)
75. Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meck WH et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) 1996; 123: 55-63.